Sireesh Appajosyula, PharmD

Chief Operating Officer

Sireesh Appajosyula joined Tharimmune as the Chief Operating Officer in July of 2023 and has served as a member of our board of directors since July 2021. Previously, he has served as SVP, Corporate Development and Operations of 9 Meters Biopharma, Inc. and as Cofounder of Highpoint Pharmaceuticals, LLC, a pharmaceutical research and development company. Dr. Appajosyula spent over 8 years at Salix Pharmaceuticals, Inc. (Nasdaq: SLXP) in various roles in medical affairs, product commercialization and business development until its acquisition by Bausch Health (Nasdaq: BHC). Prior to Salix, he was involved in various roles at Amgen Inc., Critical Therapeutics, Inc. and Sanofi (formerly Aventis). He received his Bachelor of Science and Doctor of Pharmacy from Rutgers University.